Fatal Course of Patients with metastatic Dermatofibrosarcoma protuberans under Therapy with Imatinib mesylate (Glivec®)

被引：0
|
作者：
Babic, V [1 ]
Dabrowski, E. [1 ]
Dippel, E. [1 ]
机构：
[1] Klinikum Ludwigshafen, Hautklin, Ludwigshafen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P144
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [31] Systemic therapy in advanced dermatofibrosarcoma protuberans: Imatinib and beyond.
    Gupta, Anshul
    Rastogi, Sameer
    Kumar, Santosh C.
    Barwad, Adarsh
    Dhamija, Ekta
    Panday, Rambha
    Deo, S. V. S.
    Shishak, Sorun
    Aggarwal, Aditi
    Dutta, Rimlee
    Manasa, Parisa
    Kumar, Pankaj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
    Rutkowski, Piotr
    Van Glabbeke, Martine
    Rankin, Cathryn J.
    Ruka, Wlodzimierz
    Rubin, Brian P.
    Debiec-Rychter, Maria
    Lazar, Alexander
    Gelderblom, Hans
    Sciot, Raf
    Lopez-Terrada, Dolores
    Hohenberger, Peter
    van Oosterom, Allan T.
    Schuetze, Scott M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1772 - 1779
  • [33] Dermatofibrosarcoma protuberans: Neoadjuvant therapy with imatinib mesylate and use of plasma PDGF-B levels to monitor clinical response.
    Macapinlac, M
    Elrafei, T
    Cunningham, I
    Horowitz, M
    Fauzia, P
    Mbaoma, R
    Jayabalan, D
    Mani, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 830S - 830S
  • [34] Using Imatinib as Neoadjuvant Therapy in Dermatofibrosarcoma Protuberans: Potential Pluses and Minuses
    Johnson-Jahangir, Hillary
    Sherman, William
    Ratner, Desiree
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (08): : 881 - 885
  • [35] Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)
    Kindmark, Henrik
    Janson, Eva Tiensuu
    Gustavsson, Bengt
    Eriksson, Camilla
    Larsson, Gunnel
    Granberg, Dan
    Kozlowacki, Gordana
    Skogseid, Britt
    Welin, Staffan
    Oberg, Kjell
    Eriksson, Barbro
    ACTA ONCOLOGICA, 2010, 49 (01) : 100 - U1
  • [36] A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec®) in Mali
    Diallo, D. A.
    Ly, M.
    Diallo, G.
    Dembele, A. K.
    Toure, M.
    Toure, B. A.
    Kone, A.
    Sidibe, S.
    Dembele, M.
    Traore, C.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (10) : 675 - 677
  • [37] Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dcrmatofibrosarcoma protuberans
    Mizutani, K
    Tamada, Y
    Hara, K
    Tsuzuki, T
    Saeki, H
    Tamaki, K
    Matsumoto, Y
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (01) : 235 - 237
  • [38] Fatal hepatic necrosis following imatinib mesylate therapy
    Lin, NU
    Sarantopoulos, S
    Stone, JR
    Galinsky, I
    Stone, RM
    Deangelo, DJ
    Soiffer, RJ
    BLOOD, 2003, 102 (09) : 3455 - 3456
  • [39] Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients
    Kerob, Delphine
    Porcher, Raphael
    Verola, Olivier
    Dalle, Stephane
    Maubec, Eve
    Aubin, Francois
    D'Incan, Michel
    Bodokh, Isaak
    Boulinguez, Serge
    Madelaine-Chambrin, Isabelle
    Mathieu-Boue, Anne
    Servant, Jean-Marie
    de Kerviler, Eric
    Janin, Anne
    Calvo, Fabien
    Pedeutour, Florence
    Lebbe, Celeste
    CLINICAL CANCER RESEARCH, 2010, 16 (12) : 3288 - 3295
  • [40] Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: Results of a multicentric phase II study on 25 patients
    Misset, J.
    Kerob, D.
    Porcher, R.
    Verola, O.
    Dalle, S.
    Maubec, E.
    Madelaine-Chambrin, I.
    Calvo, F.
    Mathieu-Boue, A.
    Pedeutour, F.
    Lebbe, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345